TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive NCI Launches M-PACT Next-Generation Trial As Group System Nears March 1 Transition February 21, 2014
